Susquehanna International Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $585K | Buy |
155,183
+49,559
| +47% | +$187K | ﹤0.01% | 4108 |
|
2025
Q1 | $478K | Buy |
105,624
+2,174
| +2% | +$9.85K | ﹤0.01% | 4399 |
|
2024
Q4 | $731K | Sell |
103,450
-30,923
| -23% | -$219K | ﹤0.01% | 3464 |
|
2024
Q3 | $1.09M | Buy |
134,373
+102,125
| +317% | +$831K | ﹤0.01% | 2570 |
|
2024
Q2 | $206K | Sell |
32,248
-17,392
| -35% | -$111K | ﹤0.01% | 4699 |
|
2024
Q1 | $374K | Buy |
49,640
+7,963
| +19% | +$60K | ﹤0.01% | 3895 |
|
2023
Q4 | $386K | Buy |
41,677
+189
| +0.5% | +$1.75K | ﹤0.01% | 4209 |
|
2023
Q3 | $420K | Sell |
41,488
-35,192
| -46% | -$356K | ﹤0.01% | 3652 |
|
2023
Q2 | $959K | Buy |
76,680
+21,529
| +39% | +$269K | ﹤0.01% | 2774 |
|
2023
Q1 | $644K | Buy |
55,151
+30,325
| +122% | +$354K | ﹤0.01% | 3497 |
|
2022
Q4 | $264K | Sell |
24,826
-50,414
| -67% | -$536K | ﹤0.01% | 4079 |
|
2022
Q3 | $730K | Buy |
+75,240
| New | +$730K | ﹤0.01% | 2972 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 6153 |
|
2022
Q1 | – | Sell |
-18,397
| Closed | -$729K | – | 6078 |
|
2021
Q4 | $729K | Buy |
18,397
+10,460
| +132% | +$414K | ﹤0.01% | 3277 |
|
2021
Q3 | $397K | Buy |
+7,937
| New | +$397K | ﹤0.01% | 3981 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 5564 |
|
2021
Q1 | – | Sell |
-6,958
| Closed | -$303K | – | 5394 |
|
2020
Q4 | $303K | Sell |
6,958
-2,293
| -25% | -$99.9K | ﹤0.01% | 3878 |
|
2020
Q3 | $339K | Sell |
9,251
-17,725
| -66% | -$650K | ﹤0.01% | 3400 |
|
2020
Q2 | $787K | Buy |
26,976
+14,385
| +114% | +$420K | ﹤0.01% | 2427 |
|
2020
Q1 | $329K | Buy |
+12,591
| New | +$329K | ﹤0.01% | 3335 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 4333 |
|